Ronald Yamamoto Chief Scientific Officer

Ronald is co-founder, Chief Scientific Officer, and a Board Observer of Oxular. With more than 30 years of medical device and drug product development experience, Ronald has led multi-disciplinary technical teams, clinical trial development, and product registration in the US, the EU, China, and Brazil. His ophthalmic experience includes the development of novel microcatheters for …

Ronald Yamamoto Chief Scientific Officer Read More »

Geert-Jan Mulder, MD

Geert-Jan is Managing Partner at Forbion and has a leading role in the firm’s investment team and portfolio. He is an experienced life sciences investor who is led Forbion’s successful investments and served on the Boards of several Forbion portfolio companies, sometimes also in an executive capacity. In addition to his portfolio management activities, he …

Geert-Jan Mulder, MD Read More »

Scroll to Top